Bicara Therapeutics, a clinical-stage biopharmaceutical company focused on bifunctional therapies for solid tumors, will announce its third quarter 2026 financial results and business updates on November 9, 2026, before the market opens. The company will hold a conference call at 8:30 a.m. ET to discuss these results. Bicara's lead program, ficerafusp alfa, targets cancer by blocking EGFR and TGF-β pathways, aiming to improve treatment outcomes in solid tumors like head and neck squamous cell carcinoma. Investors and interested parties can access the live webcast or replay via the company's website.
Bicara Therapeutics' upcoming third quarter 2026 financial results provide context for healthcare sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 02, 2026 20:02 WIB: out of 150 priced US health-sector stocks, 87 rose and 43 fell. Notable movers include Inovio Pharmaceuticals Inc (INO) up 263.55% at USD 2.19 with a typical hold time of 43 days, IDEXX Laboratories, Inc. (IDXX) up 6.49% at USD 586.99, and Cassava Sciences Inc (FLNA) up 6.11% at USD 0.66.
Maurizio Mian, known as the pioneer of influencer culture, has launched a new micro-drama series called 'The Experiment.' The show features popular social media personalities living in luxury while exploring whether happiness can be measured and incr...
The global wealth management software market, valued at $6.28 billion in 2025, is projected to reach $18.77 billion by 2033, growing at a 14.7% CAGR. Growth is fueled by rising adoption of AI, automation, and digital advisory tools that enhance workf...
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
